GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,445 Cr | ₹-828 Cr | ₹-265 Cr | ₹625 Cr | ₹1,109 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3,445 Cr |
| Mar2025 | ₹-828 Cr |
| Mar2024 | ₹-265 Cr |
| Mar2023 | ₹625 Cr |
| Mar2022 | ₹1,109 Cr |
How is Cash Flow from Operating Activities of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,445 Cr | Positive | |
| Mar2025 | ₹-828 Cr | Negative | |
| Mar2024 | ₹-265 Cr | Negative | |
| Mar2023 | ₹625 Cr | -43.59 | |
| Mar2022 | ₹1,109 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹69,308.3 Cr | 6.5% | 8.6% | 25.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 6.5% |
8.6% |
25.7% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses